질병 예측 플랫폼 시장 보고서(2025년)
Disease Forecasting Platform Global Market Report 2025
상품코드 : 1855864
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,661,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,629,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,596,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 질병 예측 플랫폼 시장 규모는 최근 급격히 확대되고 있습니다. 2024년 22억 2,000만 달러에서 2025년에는 27억 6,000만 달러에 달하고, CAGR 24.0%로 확대될 것으로 보입니다. 실적기간의 성장은 전염병 증가, 정부 공중보건 대비의 중요성, 클라우드 기반 의료 솔루션의 광범위한 채택, 빅데이터 및 역학 모델링의 활용 확대, IoT 대응 건강 모니터링 시스템의 통합으로 인한 것입니다.

질병 예측 플랫폼 시장 규모는 향후 수년간 비약적인 성장이 예상됩니다. 2029년까지 CAGR 23.7%로 64억 4,000만 달러로 성장할 것으로 보입니다. 예측 기간의 성장은 정밀의료 프로그램 확대, 실시간 질병 모니터링에 대한 수요 증가, 건강 관리 및 기술 기업 간의 협력 관계 확대, 디지털 건강 인프라 투자 증가, 고급 데이터 시각화 및 대시보드 도구 채택으로 인한 것입니다. 예측기간의 주요 동향으로는 예측 모델링을 위한 생성 인공지능의 통합, 안전한 데이터 공유를 위한 연계 학습의 이용, 투명성이 높은 건강 데이터 관리를 위한 블록체인의 도입, 보다 신속한 분석을 위한 엣지 컴퓨팅의 전개, 질병 시뮬레이션을 위한 디지털 트윈의 개발 등이 있습니다.

비전염성 질환의 유병률 상승이 질병 예측 플랫폼 시장의 성장을 가속할 것으로 예측됩니다. 비전염성 질환이란, 전염성이 없고, 일반적으로 유전적, 생활습관적, 환경적 요인에 의해 발생하는 병으로, 심장병, 당뇨병, 암 등이 포함됩니다. 이러한 질병은 식생활의 혼란, 흡연, 운동 부족과 같은 건강에 해로운 행동으로 인해 증가하고 있습니다. 질병 예측 플랫폼은 빅데이터 분석, 머신러닝, 실시간 건강 모니터링을 이용하여 질병 동향을 예측하고, 고위험 그룹을 식별하고, 조기 개입을 가능하게 하며, 개별화된 예방 전략을 이끌어 비전염성 질병 관리를 지원합니다. 이러한 노력은 공중 보건의 성과를 개선하고 만성 질환의 부담을 줄입니다. 예를 들어 스위스에 본부를 두고 있는 유엔의 전문기관인 세계보건기구(WHO)는 2022년 전 세계에서 4,100만명(전체 사망의 74%)이 만성질환으로 사망한다고 보고했습니다. 그 내역은 심혈관질환에 의한 사망이 1,790만명, 암에 의한 사망이 930만명, 만성 호흡기 질환에 의한 사망이 410만명, 당뇨병에 의한 사망이 200만명으로 되어 있습니다. 이러한 유병률 증가가 질병 예측 플랫폼에 대한 수요를 부추기고 있습니다.

이 시장의 주요 기업은 실시간 질병 모니터링을 가능하게하고 적극적인 공중 보건 대응을 지원하기 위해 인공지능 주도의 예측 분석을 채택하고 있습니다. AI 주도 예측 분석은 머신러닝 및 통계 모델링과 같은 AI 기술을 적용하여 미래의 질병 패턴을 예측하고, 이상을 조기에 발견하고, 적시 개입과 자원 관리를 위한 실행 가능한 인사이트력을 제공합니다. 예를 들어 2025년 7월 한국의 생명공학 기업인 Seegene Inc.는 STAgora 플랫폼을 발표했습니다. 이 플랫폼은 PCR 기반 진단 데이터와 40개 이상의 고급 AI 및 통계 도구를 통합하여 실시간으로 전염성 감염의 추세를 시각화합니다. 이 플랫폼은 병원체 비정상 활동의 조기 발견, 발생 예측 모델링, 지역 수준에서 세계 수준까지의 상황 인식을 지원합니다. 실시간 감염성 인텔리전스 시스템으로 설계된 STAgora는 신속한 상황 인식을 강화하고 적극적인 공중 보건 활동을 가능하게 합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

JHS
영문 목차

영문목차

A disease forecasting platform is a digital system that leverages data analytics, artificial intelligence, and predictive modeling to predict the spread, severity, and impact of diseases. It combines real-time health, environmental, and demographic data to provide early warnings. These insights support timely interventions, resource allocation, and mitigation of outbreak risks.

The primary components of a disease forecasting platform are software, hardware, and services. Software includes the programs, applications, and algorithms used to process, analyze, and visualize health data, enabling predictive modeling, simulation, and reporting of disease trends. Deployment modes include cloud-based and on-premises solutions. Applications cover infectious disease surveillance, chronic disease management, epidemiology, public health, and others. These platforms are utilized by hospitals and clinics, government and public health agencies, research institutions, pharmaceutical companies, and other end-users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The disease forecasting platform market research report is one of a series of new reports from The Business Research Company that provides disease forecasting platform market statistics, including disease forecasting platform industry global market size, regional shares, competitors with a disease forecasting platform market share, detailed disease forecasting platform market segments, market trends and opportunities, and any further data you may need to thrive in the disease forecasting platform industry. The disease forecasting platform market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The disease forecasting platform market size has grown exponentially in recent years. It will grow from $2.22 billion in 2024 to $2.76 billion in 2025 at a compound annual growth rate (CAGR) of 24.0%. The growth in the historic period can be attributed to increasing outbreaks of infectious diseases, government emphasis on public health preparedness, wider adoption of cloud-based healthcare solutions, greater use of big data and epidemiological modeling, and integration of IoT-enabled health monitoring systems.

The disease forecasting platform market size is expected to see exponential growth in the next few years. It will grow to $6.44 billion in 2029 at a compound annual growth rate (CAGR) of 23.7%. The growth in the forecast period can be attributed to the expansion of precision medicine programs, rising demand for real-time disease surveillance, growing collaboration between healthcare and technology companies, increased investment in digital health infrastructure, and adoption of advanced data visualization and dashboard tools. Key trends in the forecast period include integration of generative artificial intelligence for predictive modeling, use of federated learning for secure data sharing, implementation of blockchain for transparent health data management, deployment of edge computing for faster analysis, and development of digital twins for disease simulation.

The rising prevalence of non-communicable diseases is expected to drive growth in the disease forecasting platform market. Non-communicable diseases are medical conditions that are not contagious and typically develop due to genetic, lifestyle, or environmental factors, including heart disease, diabetes, and cancer. These diseases are increasing due to unhealthy behaviors such as poor diet, smoking, and physical inactivity. Disease forecasting platforms aid in managing non-communicable diseases by using big data analytics, machine learning, and real-time health monitoring to predict disease trends, identify high-risk groups, enable early interventions, and guide personalized prevention strategies. These efforts improve public health outcomes and reduce the burden of chronic illnesses. For example, the World Health Organization (WHO), a United Nations specialized agency based in Switzerland, reported that in 2022, 41 million deaths globally-74% of all deaths-were caused by chronic diseases. These included 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. This growing prevalence is fueling demand for disease forecasting platforms.

Key companies in this market are adopting artificial intelligence-driven predictive analytics to enable real-time disease surveillance and support proactive public health responses. AI-driven predictive analytics involves applying AI technologies such as machine learning and statistical modeling to forecast future disease patterns, detect anomalies early, and provide actionable insights for timely interventions and resource management. For instance, in July 2025, Seegene Inc., a biotechnology company based in South Korea, launched the STAgora platform. This platform integrates PCR-based diagnostic data with over 40 advanced AI and statistical tools to offer real-time global visualization of infectious disease trends. It supports early detection of abnormal pathogen activity, predictive outbreak modeling, and situational awareness from local to global levels. Designed as a real-time infectious disease intelligence system, STAgora enhances rapid situational awareness and enables proactive public health action.

In March 2024, Healthy Together, a US-based health technology company specializing in SaaS solutions, acquired Kinsa Health for an undisclosed sum. This acquisition enables Healthy Together to incorporate Kinsa Health's AI-powered illness forecasting technology into its SaaS offerings, strengthening real-time disease surveillance, expanding into new markets, and delivering early outbreak detection and predictive insights to public and private healthcare organizations. Kinsa Health, based in the US, provides AI-driven illness forecasting tools that use smart thermometers, mobile apps, and predictive analytics to offer real-time early warnings and track community-level infectious disease trends.

Major players in the disease forecasting platform market are International Business Machines Corporation, Oracle Corporation, Metabiota Inc., SAS Institute Inc., Tempus AI Inc., HealthVerity Inc., Airfinity Ltd., Quantori LLC, ProMED-mail Inc., EcoHealth Alliance Inc., BlueDot Inc., Hyfe Inc., Biobot Analytics Inc., Cayaba Care Inc., EPIWATCH Pty Ltd, GIDEON Informatics Inc., Kinsa Inc., Epistemix, Epidemico Inc., EpiDetect AI Inc.

North America was the largest region in the disease forecasting platform market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in disease forecasting platform report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the disease forecasting platform market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The disease forecasting platform market consists of revenues earned by entities by providing services such as data collection, data integration, predictive modeling, real-time monitoring, analytics and visualization. The market value includes the value of related goods sold by the service provider or included within the service offering. The disease forecasting platform market also includes sales of sensors, servers, data storage systems, networking equipment, edge devices, and monitoring devices. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Disease Forecasting Platform Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on disease forecasting platform market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for disease forecasting platform ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The disease forecasting platform market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Disease Forecasting Platform Market Characteristics

3. Disease Forecasting Platform Market Trends And Strategies

4. Disease Forecasting Platform Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Disease Forecasting Platform Growth Analysis And Strategic Analysis Framework

6. Disease Forecasting Platform Market Segmentation

7. Disease Forecasting Platform Market Regional And Country Analysis

8. Asia-Pacific Disease Forecasting Platform Market

9. China Disease Forecasting Platform Market

10. India Disease Forecasting Platform Market

11. Japan Disease Forecasting Platform Market

12. Australia Disease Forecasting Platform Market

13. Indonesia Disease Forecasting Platform Market

14. South Korea Disease Forecasting Platform Market

15. Western Europe Disease Forecasting Platform Market

16. UK Disease Forecasting Platform Market

17. Germany Disease Forecasting Platform Market

18. France Disease Forecasting Platform Market

19. Italy Disease Forecasting Platform Market

20. Spain Disease Forecasting Platform Market

21. Eastern Europe Disease Forecasting Platform Market

22. Russia Disease Forecasting Platform Market

23. North America Disease Forecasting Platform Market

24. USA Disease Forecasting Platform Market

25. Canada Disease Forecasting Platform Market

26. South America Disease Forecasting Platform Market

27. Brazil Disease Forecasting Platform Market

28. Middle East Disease Forecasting Platform Market

29. Africa Disease Forecasting Platform Market

30. Disease Forecasting Platform Market Competitive Landscape And Company Profiles

31. Disease Forecasting Platform Market Other Major And Innovative Companies

32. Global Disease Forecasting Platform Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Disease Forecasting Platform Market

34. Recent Developments In The Disease Forecasting Platform Market

35. Disease Forecasting Platform Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기